If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE

14 Dec 2022 07:00

RNS Number : 5933J
JPEL Private Equity Limited
14 December 2022
 

JPEL Private Equity Limited

Ground Floor

Cambridge House

Le Truchot, St Peter Port

Guernsey, GY1 1WD

www.jpelonline.com

 

 

ELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE

 

 

 

· JPEL WILL RETURN $8.5 MILLION TO SHAREHOLDERS

 

· REDEMPTION DATE 21 December 2022

 

· REDEMPTION REPRESENTS 16.2% OF US$ EQUITY SHAREHOLDER NET ASSET VALUE AT 30 SEPTEMBER 2022 

 

· REDEMPTION REPRESENTS 23.4% OF JPEL's MARKET CAPITALIZATION AT 13 DECEMBER 2022

 

· Macroenvironment resulting in A POTENTIAL slowing OF realisation timing

 

 

* * *

 

GUERNSEY, 14 DECEMBER 2022

 

 

The Company is pleased to announce its eleventh Mandatory Redemption to US$ Equity Shareholders. The amount of the redemption will be $8.5 million or 16.2% of NAV at 30 September 2022 (approximately 23.4% of JPEL's market capitalization at 13 December 2022).

 

The $8.5 million capital return (the equivalent of approximately 4.9 million US$ Equity Shares will be by way of a pro rata compulsory redemption of US$ Equity Shares at a price equal to the prevailing NAV per US$ Equity Share of $1.73 as at 30 September 2022 (being the most recent NAV per US$ Equity Share available as of the date of this announcement) for US$ Equity Shareholders on the register of members as at close of business on 21 December 2022 ("Record Date"). Unless circumstances require otherwise, this NAV will form the NAV per US$ Equity Share as of the date of redemption.

 

Payments of redemption proceeds are expected to be effected either through CREST (in the case of shares held in uncertificated form) or by cheque (in the case of shares held in certificated form) on or around 3 January 2023. Any share certificates for the balance of holdings of shares will also be despatched to shareholders on or 3 January 2023.

 

The Company currently has 30,288,238 US$ Equity Shares in issue. All of the US$ Equity Shares redeemed on the redemption date will be cancelled and any fractions of shares will be rounded down to the nearest whole share.

 

The US$ Equity Shares will be disabled in CREST on the Record Date and the existing ISIN number GG00BMFD2F62 (the "Old ISIN") will expire. A new ISIN number GG00BPSMLX26 (the "New ISIN") in respect of the remaining US$ Equity Shares which have not been redeemed will be enabled and available for transactions on 22 December 2022 (the "Ex-date"). For the period up to and including the Record date, US$ Equity Shares will be traded under the Old ISIN and as such, a purchaser of such shares may have a market claim for the redemption proceeds following the activation of the New ISIN. CREST will automatically transfer any open transactions as at the redemption date to the New ISIN.

 

Inclusive of this Mandatory Redemption, JPEL will have returned $525.7 million to US$ Equity Shareholders, or approximately 109.7% and 138.3% of the Company's 31 October 2016 NAV and market capitalization. Please note that the prevailing NAV at the time of the Company's first mandatory redemption was 31 October 2016.

 

SHAREHOLDER UPDATE

 

As JPEL continues to run-off its portfolio organically, the Board would like to remind shareholders that it will revisit a variety of options once JPEL's NAV approaches approximately $30 million. As global markets continue to be affected by well documented macroeconomic factors, the JPEL portfolio may be impacted, similar to other private equity funds, in timing, valuation, or amounts of realisation activity. As a result, distributions in 2023 are likely to be unpredictable. The Board are pleased to have implemented the bulk of the cost reduction plan previously outlined.

 

DIRECTOR'S INTERESTS

 

As of 14 December 2022, Sean Hurst and Tony Dalwood, Directors of the Company, owned 2,234 and 11,450 US$ Equity Shares, respectively. As a result of the Mandatory Redemption described above, Sean Hurst and Tony Dalwood are expected, immediately following the redemption date, to hold approximately 1,977 and 10,132 US$ Equity Shares, respectively.

 

 

* * *

 

 

LEI Number: 5493005M6GBE3DNJZ894

 

 

 

 

About JPEL Private Equity Limited

 

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CASEAKADFLFAFFA
Date   Source Headline
15th Nov 20195:52 pmRNSNet Asset Value(s) - September
15th Nov 20195:51 pmRNSNet Asset Value(s) - August 2019
15th Nov 20195:51 pmRNSNet Asset Value(s) - July 2019
5th Nov 20195:42 pmRNS2019 AGM CIRCULAR
22nd Oct 20197:00 amRNSCompletion of Sixth Mandatory Redemption
9th Oct 20193:28 pmRNSSixth Mandatory Redemption
27th Sep 201910:48 amRNSAnnual Financial Report - 30 June 2019
10th Sep 20191:19 pmRNSNet Asset Value(s) - June 2019
12th Jul 20197:00 amRNSNet Asset Value(s) - May 2019
13th Jun 20197:00 amRNSNet Asset Value(s) - April 2019
17th May 20197:00 amRNSNet Asset Value(s) - March 2019
5th Apr 20197:00 amRNSNet Asset Value(s) - February 2019
19th Mar 20193:57 pmRNSHalf-year Report - 31 December 2018
13th Mar 20197:00 amRNSNet Asset Value(s)
7th Feb 201910:55 amRNSNet Asset Value(s) - December 2018
22nd Jan 201910:10 amRNSNet Asset Value(s) - November 2018
8th Jan 20197:00 amRNSCompletion Of Fifth Mandatory Redemption
10th Dec 20183:58 pmRNSMandatory Redemption - US$Equity Shares - Dec 2018
6th Dec 20183:28 pmRNSHolding(s) in Company
30th Nov 20183:21 pmRNSNet Asset Value(s) - October 2018
27th Nov 201811:08 amRNSAGM Results 2018
7th Nov 20187:00 amRNS2018 AGM CIRCULAR
30th Oct 20187:00 amRNSNet Asset Value(s) - August 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - September 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - July 2018
12th Oct 20184:32 pmRNSHolding(s) in Company
4th Oct 20182:42 pmRNSNotification of Dealings in Shares
28th Sep 20181:10 pmRNSAnnual Financial Report - 30 June 2018
17th Sep 20187:00 amRNSNet Asset Value(s) - June 2018
22nd Aug 20185:11 pmRNSHolding(s) in Company
20th Jul 20187:00 amRNSNet Asset Value(s) - May 2018
3rd Jul 20187:00 amRNSNet Asset Value(s) - April 2018
9th May 20187:00 amRNSNet Asset Value(s) - March 2018
13th Apr 20189:30 amRNSNet Asset Value(s) - February 2018
11th Apr 20187:00 amRNSNotice to Shareholders - Total Voting Rights
10th Apr 20182:24 pmRNSCompletion of Fourth Mandatory Redemption
22nd Mar 20187:00 amRNSHalf-year Report - 31 December 2017
22nd Mar 20187:00 amRNSMandatory Redemption- US$Equity Shares -April 2018
12th Mar 20187:00 amRNSNet Asset Value(s) - January 2018
2nd Feb 20187:00 amRNSNet Asset Value(s) - December 2017
15th Jan 20187:00 amRNSNet Asset Value(s) - November 2017
29th Dec 20171:15 pmRNSNotice to Shareholders - Key Information Document
14th Dec 20175:50 pmRNSNotice to Shareholders - Total Voting Rights
14th Dec 20177:00 amRNSCompletion Of Third Mandatory Redemption
4th Dec 20172:52 pmRNSAGM Results
4th Dec 20179:44 amRNSNet Asset Value(s) - October 2017 Review
1st Dec 20177:05 amRNSMandatory Redemption - US$Equity Shares - Dec 2017
1st Dec 20177:00 amRNSNet Asset Value(s) - October 2017
24th Nov 20177:00 amRNSSale of Celerion
20th Nov 20172:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.